16results about "Ball valves" patented technology

A system and method for reducing ventricular filling volume is disclosed. A stimulation circuit is used to stimulate a patient's heart to reduce ventricular filling or blood pressure. Stimulating the heart to a certain degree to reduce blood pressure may cause the cardiovascular system to eventually adapt to the stimulation and return to a higher blood pressure. To reduce or prevent the heart's adaptive response, the stimulation pattern may be configured inconsistently, and the stimulation circuit may be used to stimulate the patient's heart to cause at least some of the atrial contractions with the atrioventricular valves closed. Such atrial contractions allow less blood to enter the corresponding ventricle than when the atrioventricular valves are open throughout the entire atrial contraction.

Methods and devices for reducing ventricle filling volume are disclosed. In some embodiments, an electrical stimulator may be used to stimulate a patient's heart to reduce ventricle filling volume or even blood pressure. When the heart is stimulated in a consistent way to reduce blood pressure, the cardiovascular system may over time adapt to the stimulation and revert back to the higher blood pressure. In some embodiments, the stimulation pattern may be configured to be inconsistent such that the adaptation response of the heart is reduced or even prevented. In some embodiments, an electrical stimulator may be used to stimulate a patient's heart to cause at least a portion of an atrial contraction to occur while the atrioventricular valve is closed. Such an atrial contraction may deposit less blood into the corresponding ventricle than when the atrioventricular valve is opened throughout an atrial contraction.

The invention relates to an access and occluder device, and in particular a heart valve regurgitation drum and optional closure disk and / or tubular stent to manage and provide levels of intentional regurgitation within a transcatheter heart valve replacement, and in particular, an orthogonally delivered transcatheter prosthetic heart valve having a first inner flow control component / valve, a second inner regurgitation control component, and an outer annular support frame having compressible wire cells that facilitate folding flat along the z-axis and compressing the valve vertically along the y-axis, or orthogonally to the central axis of the flow control component, allowing a very large diameter valve to be delivered and deployed to the tricuspid valve from the inferior vena cava or superior vena cava, or trans-atrrally to the mitral valve, the valve having a height of about 5-60mm and a diameter of about 25-80mm, without requiring an oversized diameter catheter and without requiring delivery and deployment from a catheter at an acute angle of approach.

The invention relates to a tricuspid regurgitation control device for an orthogonal transcatheter heart valve prosthesis. The invention also relates to access and occluder devices, in particular heart valve regurgitation drums and optionally closure discs and / or tubular stents, for managing and providing intentional regurgitation levels within transcatheter heart valve substitutes and in particular orthogonally delivered transcatheter prosthetic heart valves, an orthogonal delivery transcatheter prosthetic heart valve has a first inner flow control member / valve, a second inner reflux control member, and an outer annular support frame with a compressible wire unit that facilitates flat folding along the z-axis and compression of the valve vertically along the y-axis or orthogonal to the central axis of the flow control member, the present invention relates to a valvular delivery and deployment system, in particular to a valvular delivery and deployment system, which allows delivery and deployment of very large diameter valves from the inferior or superior vena cava to the tricuspid valve or trans-atrial delivery and deployment to the mitral valve, the valves having a height of about 5-60 mm and a diameter of about 25-80 mm, without extra-large diameter catheters and without delivery and deployment from catheters at acute access angles.

The invention relates to an access and occluder device, and in particular a heart valve regurgitation drum and optional closure disk and / or tubular stent to manage and provide levels of intentional regurgitation within a transcatheter heart valve replacement, and in particular, an orthogonally delivered transcatheter prosthetic heart valve having a first inner flow control component / valve, a second inner regurgitation control component, and an outer annular support frame having compressible wire cells that facilitate folding flat along the z-axis and compressing the valve vertically along the y-axis, or orthogonally to the central axis of the flow control component, allowing a very large diameter valve to be delivered and deployed to the tricuspid valve from the inferior vena cava or superior vena cava, or trans-atrrally to the mitral valve, the valve having a height of about 5-60mm and a diameter of about 25-80mm, without requiring an oversized diameter catheter and without requiring delivery and deployment from a catheter at an acute angle of approach.

The present invention relates to an access and occluder device, in particular a heart valve regurgitation drum and optional occlusion disc and / or annular stent for managing and providing a level of intentional regurgitation in a transcatheter heart valve replacement, in particular an orthogonally delivered transcatheter prosthetic heart valve having a first inner flow control component / valve, a first inner regurgitation control component and an outer annular support frame having compressible wire cells.SOLUTION: The compressible wire cells facilitate folding flat along the z-axis and compressing the valves vertically along the y-axis or orthogonal to the central axes of the flow control components, enabling the delivery and placement of very large diameter valves from the inferior or superior vena cavae to the tricuspid valves or transatrially to the mitral valves, having heights of about 5 to 60mm and diameters of about 25 to 80mm, without the need for an oversized catheter and without the need for delivery and placement from a catheter with a sharp approach angle.SELECTED DRAWING: Figure 3

The invention relates to an access and occluder device, and in particular a heart valve regurgitation drum and optional closure disk and / or tubular stent to manage and provide levels of intentional regurgitation within a transcatheter heart valve replacement, and in particular, an orthogonally delivered transcatheter prosthetic heart valve having a first inner flow control component / valve, a second inner regurgitation control component, and an outer annular support frame having compressible wire cells that facilitate folding flat along the z-axis and compressing the valve vertically along the y-axis, or orthogonally to the central axis of the flow control component, allowing a very large diameter valve to be delivered and deployed to the tricuspid valve from the inferior vena cava or superior vena cava, or trans-atrrally to the mitral valve, the valve having a height of about 5-60mm and a diameter of about 25-80mm, without requiring an oversized diameter catheter and without requiring delivery and deployment from a catheter at an acute angle of approach.

The application belongs to the technical field of medical devices, and particularly relates to a heart valve replacement system, which comprises: a valve support, the valve support is a single-layer self-expanding structure, the valve support comprises a support body and a skirt structure which are integrally connected from an outflow end to an inflow end; and an anchoring support, the anchoring support is a spherical structure, the anchoring support is located on the inner side of the skirt structure and is detachably abutted on the skirt structure. The valve support of the application is a single-layer self-expanding support, the single-layer structure is conducive to compression and delivery, the valve support and the anchoring support are a detachable structure, so that they can be delivered separately, the compression diameter is small, and the delivery and implantation through the femoral artery and the like are facilitated, the two are delivered separately and are sequentially introduced into the human body, a thinner catheter can be used for delivery and implantation into the human body, and the expansion of the blood vessel is reduced.

To provide an access and occluder device, in particular a heart valve regurgitation drum and optional closure disk and / or tubular stent to manage and provide levels of intentional regurgitation within a transcatheter heart valve replacement, and in particular, an orthogonally delivered transcatheter prosthetic heart valve having a first inner flow control component / valve, a first inner regurgitation control component, and an outer annular support frame having compressible wire cells.SOLUTION: Compressible wire cells facilitate folding flat along the z-axis and compressing the valve vertically along the y-axis, or orthogonally to the central axis of the flow control component, allowing a very large diameter valve to be delivered and deployed to the tricuspid valve from the inferior vena cava or superior vena cava, or trans-atrrally to the mitral valve, the valve having a height of about 5-60 mm and a diameter of about 25-80 mm, without requiring an oversized diameter catheter and without requiring delivery and deployment from a catheter at an acute angle of approach.SELECTED DRAWING: Figure 3

Systems and methods for reducing ventricular filling volume are disclosed.SOLUTION: The stimulation circuit is used to stimulate the patient's heart to reduce ventricular filling volume or blood pressure. When the heart is stimulated to a certain degree to reduce the blood pressure, the cardiovascular system may eventually adapt to the stimulation and return to a higher blood pressure. The stimulation pattern may be inconsistently configured such that an adaptive response of the heart is reduced or prevented, and the stimulation circuitry may be used to stimulate the patient's heart to cause at least a portion of the atrial contraction with the atrioventricular valve closed. Such atrial contraction causes less blood to enter the corresponding ventricle than when the atrioventricular valve is open throughout atrial contraction.SELECTED DRAWING: Figure 9

The present invention relates to a passageway and occluder device for managing and providing intentional regurgitation levels within transcatheter heart valve replacements, and specifically ortho-delivered transcatheter prosthetic heart valves having a first inner flow control component / valve, a second inner regurgitation control component, and an outer annular support frame having a compressible wire unit that facilitates collapsing along the z-axis and compressing the valve vertically along the y-axis or orthogonally to the central axis of the flow control component, thereby allowing very large diameter valves to be delivered and deployed from the inferior vena cava or superior vena cava to the tricuspid valve, or transatrially to the mitral valve, with a height of about 5-60 mm and a diameter of about 25-80 mm, without the need for an ultra-large diameter catheter and without the need to be delivered and deployed from the catheter at an acute angle of approach.

Methods and devices for reducing ventricle filling volume are disclosed. In some embodiments, an electrical stimulator may be used to stimulate a patient's heart to reduce ventricle filling volume or even blood pressure. When the heart is stimulated in a consistent way to reduce blood pressure, the cardiovascular system may over time adapt to the stimulation and revert back to the higher blood pressure. In some embodiments, the stimulation pattern may be configured to be inconsistent such that the adaptation response of the heart is reduced or even prevented. In some embodiments, an electrical stimulator may be used to stimulate a patient's heart to cause at least a portion of an atrial contraction to occur while the atrioventricular valve is closed. Such an atrial contraction may deposit less blood into the corresponding ventricle than when the atrioventricular valve is opened throughout an atrial contraction.

A system for reducing regurgitation includes a catheter and a coaptation member disposed along a distal end portion of the catheter, wherein the coaption member is sized to be advanced through a patient's vasculature in a compressed configuration and wherein the coaptation member is expandable for deployment between leaflets of a native tricuspid valve. The coaptation member includes a frame covered with one or more panels of bioprosthetic tissue or flexible polymer to form a three-sided shape having three convex sides separated by rounded corners. An anchor is coupled to a proximal end portion of the catheter and is shaped for attachment to a vessel wall. After deployment, the anchor secures the position of the coaptation member relative to the native tricuspid valve.

The application discloses a valve stent and a valve prosthesis system, and the valve stent comprises an inner stent, a plurality of first stents and a valve ring matching part; the plurality of first stents are arranged along the axial extension of the valve stent, the outflow ends of the first stents are connected to the outside of the inner stent through the valve ring matching part, and the plurality of first stents and the valve ring matching part are arranged along the circumference of the inner stent; when the first stents are in an unfolded state, the plurality of first stents form a space with a spherical shape or a spherical-like shape for supporting an atrium; and the valve ring matching part is used for matching with a valve ring. In this way, the first stents support the atrium, the valve stent can be prevented from moving in the front-back, left-right and up-down directions and from being displaced when the heart beats, and the radial supporting force of the valve ring matching part is supported at the valve ring, so that the valve prosthesis can be further prevented from being deflected and displaced.

The present invention relates to devices and methods for improving the function of a defective heart valve, and particularly for reducing regurgitation through an atrioventricular heart valve (i.e., mitral valve and / or tricuspid valve). For tricuspid repair, the device includes an anchor deployed in the tissue of the right ventricle, in an orifice opening to the right atrium, or anchored to the tricuspid valve. A flexible anchor rail connects to the anchor and a coaptation element on a catheter rides over the anchor rail. The catheter attaches to the proximal end of the coaptation element, and a locking mechanism fixes the position of the coaptation element relative to the anchor rail. There is a proximal anchoring feature to fix the proximal end of the coaptation catheter subcutaneously adjacent the subclavian vein. The coaptation element includes an inert covering and helps reduce regurgitation through contact with the valve leaflets.

A single-leaflet mechanical valve, comprising a mechanical valve annulus (1), a limiting base (2), a movable valve leaflet (3), and a guide rod (4), wherein a connection hole (101) is provided in the middle of the mechanical valve annulus (1); the limiting base (2) is mounted at the bottom of the mechanical valve annulus (1), and an open movement region (201) is provided between the mechanical valve annulus (1) and the limiting base (2); and the movable valve leaflet (3) and the guide rod (4) are both located in the movement region (201), and the movable valve leaflet (3) can perform a reciprocating motion vertically along the trajectory direction of the guide rod (4), such that the movable valve leaflet (3) can movably open or close the entire channel opening of the connection hole (101), thereby relatively increasing the orifice area and achieving a lower transvalvular pressure gradient. By means of cooperation of the movable valve leaflet (3) and the guide rod (4), the mechanical valve can effectively avoid thrombosis, and is not easily damaged; and even if thrombosis occurs, the mechanical valve is not easily stuck, thus avoiding the risk of valve sticking or dysfunction, and enabling the reduction or elimination of anticoagulant therapy.